Arcutis Biotherapeutics CFO Executes Stock Sale Amid Recent Earnings Results
Latha Vairavan, the Senior Vice President and Chief Financial Officer of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), recently completed a transaction involving the sale of company common stock. The transaction, which took place on May 4, 2026, involved the disposal of 1,341 shares. This movement in equity occurred against a backdrop of recent fin…